Five patients without TP53 mutations, including four patients reclassified as LCCs and one non-LCC patient according to the 2015 WHO criteria, were absent of any other mutation (Figure 2A) and were alive at the time of follow-up. Here, TP53 is linked to lethal congenital contracture syndrome.